These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17954163)

  • 1. Sirolimus: efficacy in liver transplant patients with nephrotoxicity and renal insufficiency.
    Perdigoto R; Sequeira C; Tomé L; Ferrão J; Silva N; Geraldes J; Furtado E; Oliveira FJ
    Transplant Proc; 2007 Oct; 39(8):2519-21. PubMed ID: 17954163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
    Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
    Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Conversion to rapamycin in liver transpant recipients with renal insufficiency].
    Yu S; He XS; Ma Y; Hu AB; Wu LW; Zhu XF
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Nov; 29(11):2276-8. PubMed ID: 19923086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus as primary immunosuppressant for calcineurin inhibitor-related renal insufficiency after liver transplantation.
    Yang YJ; Li LX; He Q; Fan H; Jin ZK; Lang R; Kou JT; Li P; Xie DH; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):376-8. PubMed ID: 17690032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of conversion to mammalian target of rapamycin inhibitors is crucial in liver transplant recipients with impaired renal function at transplantation.
    Schleicher C; Palmes D; Utech M; Bonrath E; Senninger N; Schmidt H; Wolters H
    Transplant Proc; 2010 Sep; 42(7):2572-5. PubMed ID: 20832546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus monotherapy effectiveness in liver transplant recipients with renal dysfunction due to calcineurin inhibitors.
    Di Benedetto F; Di Sandro S; De Ruvo N; Spaggiari M; Montalti R; Ballarin R; Cappelli G; Gerunda GE
    J Clin Gastroenterol; 2009 Mar; 43(3):280-6. PubMed ID: 19057397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe sirolimus-related inflammatory state anemia in an HIV+ liver transplant patient with calcineurin inhibitor renal insufficiency: a case report.
    Moreno A; Bárcena R; García-Gonzalez M; García-Hoz F; Quereda C; Casado JL; Pérez-Elías MJ; Fortún J; Nuño J; Arranz I; Moreno S
    Transplant Proc; 2008 Dec; 40(10):3810-2. PubMed ID: 19100499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus in pediatric liver transplantation: a single-center experience.
    Gibelli NE; Tannuri U; Pinho-Apezzato ML; Tannuri AC; Maksoud-Filho JG; Andrade WC; Velhote MC; Santos MM; Ayoub AA; Marques da Silva M
    Transplant Proc; 2009 Apr; 41(3):901-3. PubMed ID: 19376384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
    DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
    Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation: impact of pretransplant renal insufficiency.
    Bahirwani R; Campbell MS; Siropaides T; Markmann J; Olthoff K; Shaked A; Bloom RD; Reddy KR
    Liver Transpl; 2008 May; 14(5):665-71. PubMed ID: 18433034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
    Bajjoka I; Hsaiky L; Brown K; Abouljoud M
    Liver Transpl; 2008 Jan; 14(1):66-72. PubMed ID: 18161842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcome after 'bottom-up' immunosuppression in liver transplant recipients with preoperative renal impairment.
    Schnitzbauer AA; Doenecke A; Sothmann JL; Loss M; Farkas SA; Hartl J; Tsui TY; Baier L; Kirchner G; Obed A; Bein T; Geissler EK; Scherer MN; Schlitt HJ
    Eur Surg Res; 2010; 45(3-4):356-67. PubMed ID: 21088426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switch to everolimus for sirolimus-induced pneumonitis in a liver transplant recipient--not all proliferation signal inhibitors are the same: a case report.
    De Simone P; Petruccelli S; Precisi A; Carrai P; Doria R; Menichetti F; Filipponi F
    Transplant Proc; 2007 Dec; 39(10):3500-1. PubMed ID: 18089420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus as the main immunosuppressant in the early postoperative period following liver transplantation: a report of six cases and review of the literature.
    Vivarelli M; Vetrone G; Zanello M; La Barba G; Cucchetti A; Lauro A; Grazi GL; Pinna AD
    Transpl Int; 2006 Dec; 19(12):1022-5. PubMed ID: 17081233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
    Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J
    Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
    Zhou J; Wang Z; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY; Fan J
    Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.